Forcefield Therapeutics launches today following £5.5m commitment from Syncona – Yahoo Finance

Forcefield Therapeutics launches today following 5.5m commitment from Syncona

New biotechnology company launched to develop pioneering, best-in-class therapeutics to protect heart function following acute myocardial infarction (AMI)

London UK, 25 April 2022 – Forcefield Therapeutics (“Forcefield”) Ltd, a pioneer of best-in-class therapeutics to protect heart function by arresting the loss of cardiomyocytes following myocardial infarction, officially launches today following a 5.5 million commitment from Syncona Ltd, a leading healthcare company focused on founding, building, and funding a portfolio of global leaders in life sciences.

Forcefield is founded on the work of Professor Mauro Giacca, an authority in cardiovascular disease and genetic biology at the School of Cardiovascular Medicine and Sciences, King’s College London. Professor Giacca and his research team discovered three naturally occurring cardioprotective proteins capable of retaining cardiac tissue damaged by acute…

Read Full Story: https://finance.yahoo.com/news/forcefield-therapeutics-launches-today-following-060000321.html

The post Forcefield Therapeutics launches today following £5.5m commitment from Syncona – Yahoo Finance first appeared on SEO, Marketing and Social News | OneSEOCompany.com.

source: https://news.oneseocompany.com/2022/04/25/forcefield-therapeutics-launches-today-following-55m-commitment-from-syncona-yahoo-finance_2022042518498.html

Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.